This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses and email address may be missing. Find their university profile.
Research
Latest papers
Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines.
The Journal of clinical investigation · 2006
Latest funding
- $100,000
BRCA1 therapy for heart failure
CIHR · 2016 · Co-investigator
- $765,000
BRCA1 therapy for heart failure
CIHR · 2016 · Principal investigator
1 publications.
Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines.
Fazel S, Cimini M, Chen L, Li S, Angoulvant D, Fedak P, Verma S, Weisel RD, Keating A, Li RK
BRCA1 therapy for heart failure
Principal investigators: Verma, Subodh S
Keywords: Brca1; Gene Delivery (Aav9-Brca1); Heart Failure; Murine Genotoxic Stress Model; Murine Hypertrophy Model; Murine Myocardial Infarction Model; Porcine Myocardial Infarction Model
BRCA1 therapy for heart failure
Principal investigators: Verma, Subodh S; Fedak, Paul William M; Singh, Krishna K
Keywords: Brca1; Gene Delivery (Aav9-Brca1); Heart Failure; Murine Genotoxic Stress Model; Murine Hypertrophy Model,; Murine Myocardial Infarction Model; Porcine Myocardial Infarction Model
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Mechanical Engineering
- Cardiovascular Surgery
- Other
Co-authors at University of Toronto, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.